Drug intelligence / Profile preview

TPMPA

Development stage
Preclinical
Modality
Small Molecules
Administration
Experimental (mainly Laboratory Use; Not Approved For Clinical Administration)[7]
01

Overview

TPMPA ((1,2,5,6-tetrahydropyridine-4-yl)methylphosphinic acid) is a synthetic small molecule that acts as a selective and competitive antagonist of GABA_A-rho receptors (previously known as GABA_C receptors). These receptors are primarily found in the retina but are also present in other tissues such as the hippocampus and spinal cord. TPMPA displays high selectivity for human recombinant ρ1 over ρ2 subtypes and has minimal effects on classical GABA_A or GABA_B receptors. It is used mainly as a pharmacological tool to investigate the function of GABA_A-rho receptors in neurophysiological research[1][2][3][4].

Other names
(1,2,5,6-tetrahydropyridine-4-yl)methylphosphinic acidmethyl(1,2,3,6-tetrahydro-4-pyridinyl)phosphinic acidP-methyl-P-(1,2,3,6-tetrahydro-4-pyridinyl)phosphinic acidPhosphinic acid, P-methyl-P-(1,2,3,6-tetrahydro-4-pyridinyl)-
02

Targets

GABRA1 (Gamma-aminobutyric acid type A receptor alpha 1 subunit)GABA-B (Gamma-aminobutyric acid receptor type B)GABRR (GABA-A receptor subunit rho)

Beyond the preview

Go deeper on TPMPA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TPMPA.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call